About CRESILON, INC
Cresilon develops advanced hemostatic gel technology that controls bleeding in seconds, targeting applications in emergency medicine, animal health, and surgical settings. The company is based in Brooklyn, NY, and has received recognition for innovation.
Develops flowable hemostatic gel technology that achieves hemostasis in secondsTargets veterinary, human trauma, and human surgical applicationsControls external moderate to severe bleeding in secondsAdapts to a wide range of wound types and geometries
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to CRESILON, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.